Clinical Trials Logo

Clinical Trial Summary

The study compares 2 medicines used for the treatment of children who are born small and who stayed small: somapacitan given once a week (a new medicine) and Norditropin® given once a day (the medicine doctors can already prescribe). Participants will either get somapacitan or Norditropin® - which treatment is decided by chance. Both participants and the study doctor will know which treatment the participants get. The study will last for 5 years. Participants will take either an injection once every week or once every day.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms

  • Dwarfism
  • Short Stature Children Born Small for Gestational Age (SGA)

NCT number NCT03878446
Study type Interventional
Source Novo Nordisk A/S
Contact
Status Active, not recruiting
Phase Phase 2
Start date July 4, 2019
Completion date December 23, 2026